QIAGENOvjeren akaunt

@QIAGEN

is a leading provider of molecular Sample to Insight solutions. Impressum:

Hilden, Germany
Vrijeme pridruživanja: svibanj 2009.

Tweetovi

Blokirali ste korisnika/cu @QIAGEN

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @QIAGEN

  1. 4. velj

    QIAGEN reports results for fourth quarter and full-year 2019

    Poništi
  2. 4. velj

    Why is cancer research important to you? Follow the link to see more statements and join the Cancer Research Community.

    Poništi
  3. 4. velj

    A person’s microbiome not only affects their overall health, but also the effectiveness of certain therapies. Dr. Hannah Wardill researches gut-species with the goal of lowering the side effects that come with oncological patient care.

    Poništi
  4. 4. velj

    Daniela develops microRNA solutions that support cancer research. Why is cancer research important to you? Follow the link to see more statements and join the Cancer Research Community.

    Poništi
  5. 4. velj

    Olusola likes to ensure cancer researchers are supported internationally. Why is cancer research important to you? Follow the link to see more statements and join the Cancer Research Community.

    Poništi
  6. 4. velj

    Mary hopes for better screening. Why is cancer research important to you? Follow the link to see more statements and join the Cancer Research Community.

    Poništi
  7. 4. velj

    Researchers like Nathalie Labarrière give the world hope: “Knowing that my team’s hard work could be part of a sea of change in oncology to save more lives is the biggest motivation.”

    Poništi
  8. 4. velj

    Why is cancer research important to you? Follow the link to see more statements and join the Cancer Research Community. Let´s conquer cancer. Together.

    Poništi
  9. 4. velj

    📢 Launching FFPE and Liquid Biopsy PIK3CA diagnostics in Europe to enhance precision medicine in advanced breast cancer: CE-IVD approved therascreen assay will be available to labs in Europe starting immediately

    Poništi
  10. 4. velj

    Brandon Mistretta and Asha Palat, both Ph.D. students at the University of Houston’s Department of Biology and Biochemistry, are working on novel ways to interfere with cancer cell signaling and, in the process, stop tumors from growing and metastasizing.

    Poništi
  11. 31. sij

    Meet us next week at Medlab 2020, Dubai. Check out our portfolio: ☑️ Booth number Z5.C10 ☑️ 3rd Feb 2020 ‐ 6th Feb 2020 ☑️ Dubai International Convention & Exhibition Centre

    Poništi
  12. 30. sij

    “The value of multianalyte approaches in liquid biopsy analysis” – Live discussion, February 4, ➡️ Join the QIAGEN Cancer Research Community, a community for dedicated and passionate researchers and get access:

    Poništi
  13. 30. sij

    Joining @see_aso right now in Abidjan, working on bringing more LTBI testing solutions to the business in Ivory Coast!

    Poništi
  14. 29. sij
    Prikaži ovu nit
    Poništi
  15. 29. sij

    What do Ct values bring to the interpretation of respiratory testing results? Dr. Utsav Pandey explains how his lab uses Ct values and amplification curves from the QIAstat-Dx Respiratory Panel to provide a more informed interpretation

    Prikaži ovu nit
    Poništi
  16. 27. sij

    Europe: FluNewsEurope -

    Prikaži ovu nit
    Poništi
  17. 27. sij

    Flu season is here, with many areas of the U.S. reporting high activity. Keep up to date with the latest in your region here: US: CDC -

    Prikaži ovu nit
    Poništi
  18. 22. sij

    “Treating latent TB means fewer drugs, fewer side effects, and shorter times for therapy.” - Dr. Eskild Petersen, Ministry of Health, Oman | Learn how ⬇️

    Poništi
  19. 21. sij

    Is your practice up-to-date? ➡️ Join our live webinar with Dr. Kawamura to discuss the newest studies on QFT-Plus ➡️ Tue, Jan 28, 2020, 7:00 PM - 8:00 PM CET

    Poništi
  20. 21. sij

    Important milestone for many patients to be tested for the JAK2 V617F mutation which presence is established as one of the major diagnostic criteria for MPN in the WHO 2016 guideline for the classification of myeloid neoplasms and acute leukemia:

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·